Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet-induced Obesity*

Background: Lipoprotein lipase regulates fat uptake into adipose tissue. Results: A mouse model with increased adipose tissue lipoprotein lipase has improved glucose metabolism when challenged with a high fat diet. Conclusion: Increasing adipose tissue lipoprotein lipase improves adipose tissue function. Significance: Adipose tissue lipoprotein lipase protects against obesity-induced glucose and insulin intolerance. Lipid accumulation in liver and skeletal muscle contributes to co-morbidities associated with diabetes and obesity. We made a transgenic mouse in which the adiponectin (Adipoq) promoter drives expression of lipoprotein lipase (LPL) in adipocytes to potentially increase adipose tissue lipid storage. These mice (Adipoq-LPL) have improved glucose and insulin tolerance as well as increased energy expenditure when challenged with a high fat diet (HFD). To identify the mechanism(s) involved, we determined whether the Adipoq-LPL mice diverted dietary lipid to adipose tissue to reduce peripheral lipotoxicity, but we found no evidence for this. Instead, characterization of the adipose tissue of the male mice after HFD challenge revealed that the mRNA levels of peroxisome proliferator-activated receptor-γ (PPARγ) and a number of PPARγ-regulated genes were higher in the epididymal fat pads of Adipoq-LPL mice than control mice. This included adiponectin, whose mRNA levels were increased, leading to increased adiponectin serum levels in the Adipoq-LPL mice. In many respects, the adipose phenotype of these animals resembles thiazolidinedione treatment except for one important difference, the Adipoq-LPL mice did not gain more fat mass on HFD than control mice and did not have increased expression of genes in adipose such as glycerol kinase, which are induced by high affinity PPAR agonists. Rather, there was selective induction of PPARγ-regulated genes such as adiponectin in the adipose of the Adipoq-LPL mice, suggesting that increasing adipose tissue LPL improves glucose metabolism in diet-induced obesity by improving the adipose tissue phenotype. Adipoq-LPL mice also have increased energy expenditure.

[1]  R. Leibel,et al.  A missing link in body weight homeostasis: the catabolic signal of the overfed state. , 2014, Cell metabolism.

[2]  M. Nikolova-Karakashian,et al.  Effect of Procysteine on aging-associated changes in hepatic GSH and SMase: evidence for transcriptional regulation of smpd3[S] , 2014, Journal of Lipid Research.

[3]  Yuhuan Wang,et al.  Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice , 2013, Journal of Lipid Research.

[4]  C. Starnes,et al.  Regulation of thrombospondin-1 expression in alternatively activated macrophages and adipocytes: role of cellular cross talk and omega-3 fatty acids. , 2013, The Journal of nutritional biochemistry.

[5]  P. Scherer,et al.  An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. , 2013, Cell metabolism.

[6]  J. M. Suh,et al.  PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.

[7]  Haowei Song,et al.  Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity. , 2012, Cell metabolism.

[8]  J. Dubé,et al.  DHA reduces the atrophy-associated Fn14 protein in differentiated myotubes during coculture with macrophages. , 2012, The Journal of nutritional biochemistry.

[9]  M. Nikolova-Karakashian,et al.  Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr−/− mice fed on a high-fat diet , 2012, Bioscience reports.

[10]  M. Taskinen,et al.  Transgenic Expression and Genetic Variation of Lmf1 Affect LPL Activity in Mice and Humans , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[11]  Hongyu Zhao,et al.  Regulation of Mitochondrial Biogenesis by Lipoprotein Lipase in Muscle of Insulin-Resistant Offspring of Parents With Type 2 Diabetes , 2012, Diabetes.

[12]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[13]  G. Hotamışlıgil,et al.  Inflammatory mechanisms in obesity. , 2011, Annual review of immunology.

[14]  R. Eckel,et al.  Deficiency of lipoprotein lipase in neurons modifies the regulation of energy balance and leads to obesity. , 2011, Cell metabolism.

[15]  P. Scherer,et al.  Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. , 2010, Endocrinology.

[16]  C. Glass,et al.  Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.

[17]  Dorothy D. Sears,et al.  PPARγ activation in adipocytes is sufficient for systemic insulin sensitization , 2009, Proceedings of the National Academy of Sciences.

[18]  R. Eckel,et al.  Lipoprotein lipase: from gene to obesity. , 2009, American journal of physiology. Endocrinology and metabolism.

[19]  R. Eckel,et al.  Skeletal Muscle–Specific Deletion of Lipoprotein Lipase Enhances Insulin Signaling in Skeletal Muscle but Causes Insulin Resistance in Liver and Other Tissues , 2008, Diabetes.

[20]  M. Lazar,et al.  PPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 , 2005 .

[21]  P. Kern,et al.  Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue. , 2005, American journal of physiology. Endocrinology and metabolism.

[22]  M. Lazar,et al.  Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. , 2005, Genes & development.

[23]  Huijun Sun,et al.  Overexpression of lipoprotein lipase in transgenic rabbits leads to increased small dense LDL in plasma and promotes atherosclerosis , 2004, Laboratory Investigation.

[24]  M. Lazar,et al.  Peroxisome proliferator-activated receptor γ in diabetes and metabolism , 2004 .

[25]  R. Ahima,et al.  Adiponectin acts in the brain to decrease body weight , 2004, Nature Medicine.

[26]  Huijun Sun,et al.  Overexpression of Lipoprotein Lipase in Transgenic Watanabe Heritable Hyperlipidemic Rabbits Improves Hyperlipidemia and Obesity* , 2004, Journal of Biological Chemistry.

[27]  R. Evans,et al.  Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.

[28]  D. Rader,et al.  Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: Evidence for an antiinflammatory role for lipoprotein lipase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Evans,et al.  PPARδ is a very low-density lipoprotein sensor in macrophages , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Lazar,et al.  A futile metabolic cycle activated in adipocytes by antidiabetic agents , 2002, Nature Medicine.

[31]  K. Petersen,et al.  Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. , 2002, The Journal of clinical investigation.

[32]  G. Shulman,et al.  Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Xu,et al.  Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. , 2000, Journal of lipid research.

[34]  G. Shulman,et al.  Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.

[35]  P. Kern,et al.  Role of Protein Kinase C in the Translational Regulation of Lipoprotein Lipase in Adipocytes* , 1999, The Journal of Biological Chemistry.

[36]  R. Zechner,et al.  Induced Mutant Mice Expressing Lipoprotein Lipase Exclusively in Muscle Have Subnormal Triglycerides yet Reduced High Density Lipoprotein Cholesterol Levels in Plasma* , 1997, The Journal of Biological Chemistry.

[37]  J Auwerx,et al.  PPARalpha and PPARgamma activators direct a distinct tissue‐specific transcriptional response via a PPRE in the lipoprotein lipase gene. , 1996, The EMBO journal.

[38]  A. Daugherty,et al.  Presence of LDL receptor-related protein/alpha 2-macroglobulin receptors in macrophages of atherosclerotic lesions from cholesterol-fed New Zealand and heterozygous Watanabe heritable hyperlipidemic rabbits. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[39]  Y. Yazaki,et al.  Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. , 1993, The Journal of biological chemistry.

[40]  M. Lazar,et al.  Peroxisome proliferator-activated receptor gamma in diabetes and metabolism. , 2004, TIPS - Trends in Pharmacological Sciences.

[41]  R. Evans,et al.  Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. , 2003, Cell.

[42]  M. Greenwood The relationship of enzyme activity to feeding behavior in rats: lipoprotein lipase as the metabolic gatekeeper. , 1985, International journal of obesity.

[43]  Green Mr The relationship of enzyme activity to feeding behavior in rats: lipoprotein lipase as the metabolic gatekeeper. , 1985 .

[44]  A. Shapiro Deficiency. , 1970, Lancet.

[45]  *To whom correspondence should be addressed at: , 2022 .